Skip to main content

Table 2 Validation of the proposed method for the determination of SER in pure form

From: Development and validation of stability indicating method for determination of sertraline following ICH guidlines and its determination in pharmaceuticals and biological fluids

Sample concentration

% recovery (repeatability)

% recovery Intermediate precision

Method I

  

12 μg/mL

100

101.34

 

102

102

 

100.9

102

X'

100.78

101.78

± SD

0.90

0.47

%RSD

0.90

0.47

% Error

0.45

0.26

20 μg/mL

101

100

 

100.55

99.76

 

99

98.56

X'

100.18

99.44

± SD

1.1

0.85

%RSD

1.1

0.85

% Error

0.63

100

Method II

  

2 μg/mL

98.50

102

 

98.43

101.5

 

99

101.8

X'

98.64

101.77

± SD

0.40

0.21

%RSD

0.40

0.21

% Error

0.24

0.12

4 μg/mL

99

99

 

99.88

98.5

 

98.88

100

X'

99.25

99.17

± SD

0.69

1.06

%RSD

0.69

1.06

% Error

0.40

0.62